Family office dealmaking doubled in February with bets on crab shells, nuclear reactors and more
A version of this article first appeared in CNBC's Inside Wealth newsletter with Robert Frank, a weekly guide to the ...
Tag: Merck & Co Inc
Pharma is hopeful about Trump’s second term — here’s what to expect for drugmakers
U.S. President Donald Trump speaks about prescription drug prices during an appearance in the Brady Press Briefing Room at the ...
Ozempic is in the next round of Medicare drug price negotiations. See the full list of 15 medications
A pharmacist displays boxes of Ozempic, a semaglutide injection drug used for treating Type 2 diabetes made by Novo Nordisk, ...
Merck says experimental RSV treatment protected infants in trial, paving way for potential approval
The logo for Merck is displayed on a screen at the New York Stock Exchange on Nov. 17, 2021.Andrew Kelly ...
Moderna stock falls 20% as it slashes guidance on low EU sales, tough U.S. vaccine market
The Moderna Inc. headquarters in Cambridge, Massachusetts, US, on Tuesday, March 26, 2024. Adam Glanzman | Bloomberg | Getty ImagesModerna on ...
Merck beats earnings expectations, raises sales outlook on strong demand for top drugs like Keytruda
The exterior view of the entrance to Merck headquarters in Rahway, New Jersey, on Feb. 5, 2024.Spencer Platt | Getty ...
FDA approves Merck vaccine designed to protect adults from bacteria that can cause pneumonia, serious infections
Zoom In IconArrows pointing outwardsMerck's new pneumococcal vaccine. Courtesy: MerckThe Food and Drug Administration on Monday approved Merck's new vaccine ...
Pfizer is betting big on cancer drugs to turn business around after Covid decline – here’s what to know
Nurphoto | Nurphoto | Getty ImagesPfizer is ready to move on from Covid. Now, the company is betting on cancer drugs ...
Merck results beat expectations as top drugs Keytruda, Gardasil post strong sales
The logo for Merck & Co. is displayed on a screen at the New York Stock Exchange (NYSE) in New ...
Big pharma is at a crossroads, as J&J, Merck and others prepare to lose heaps of revenue from blockbuster drugs
The New York Stock Exchange welcomes Johnson & Johnson (NYSE: JNJ) to the podium. NYSEBig pharmaceutical companies such as Bristol Myers ...
